Resources

Dr. Didier Bakajika of the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis presented WHO's expectations for countries seeking validation of LF elimination and the goals of the WHO's 2030 NTD Roadmap.

Le Dr Ernest Mensah de FHI 360 a donné un aperçu de l'atelier de l'USAID sur l'enquête d'évaluation de la transmission de la filariose lymphatique le 14 janvier 2020.

USAID's Act to End NTDs | West program will support the elimination of neglected tropical diseases (NTDs) in Benin, Burkina Faso, Cameroon, Ghana, Guinea, Cote d’Ivoire, Mali, Niger, Senegal, Sierra Leone and Togo. The program seeks to build upon the achievements of the END in Africa and ENVISION projects in West Africa in their efforts to eliminate lymphatic filariasis (LF) and trachoma as public health problems, and onchocerciasis (OV) in selected countries. It aims to enable Neglected Tropical Disease programs (NTDPs) to sustain treatment for long-term control programs for schistosomiasis (SCH), soil-transmitted helminths (STH) and OV and to mainstream NTDPs into the national health system. The Act to End NTDs | West FY2020 Work Plan is built upon the accumulated experience and lessons learned in NTD programs in West Africa and the current program’s first year of implementation, directly by FHI 360 or in collaboration with our partners.

The USAID Act to End NTDs | West program's two-phase gender analysis examines the differential impact of NTDs by gender, including how gender norms and power differentials may impact NTD program results and how the program can help advance gender equality. Phase one of the gender analysis consists of a literature review, drawing on published and grey literature, as well as an initial analysis of available quantitative data.